First autochthonous transmission of West Nile virus (WNV) lineage 2 to humans in Spain
M. Fernanda Lara, Carlos S. Casimiro‐Soriguer, Irene Pedrosa-Corral, Cristina Gómez-Camarasa, Nicola Lorusso, José María Navarro‐Marí, Joaquı́n Dopazo, Javier Pérez-Florido, Sara Sanbonmatsu‐Gámez
Abstract
West Nile Virus (WNV) lineage 2, primarily endemic to parts of Africa and Europe, has recently emerged as a public health concern in new geographic regions. In 2024, the first autochthonous human case of neuroinvasive disease caused by WNV lineage 2 was identified in Andalusia, Southern Spain. Molecular testing and whole-genome sequencing confirmed WNV lineage 2 as the causative agent. Phylogenetic analysis revealed a close relationship with strains circulating in Central Europe, distinct from previous WNV lineage 2 detections in Spain. Concurrently, WNV lineage 2 RNA was detected in an imperial eagle near the case location, suggesting local viral circulation. This case marks a significant shift in WNV epidemiology in Spain, where lineage 1 has historically been dominant. The findings underscore the expanding range of WNV lineage 2 and the necessity for enhanced vector surveillance, genomic monitoring, and strengthened One Health strategies to mitigate future outbreaks and protect public health. • First human case of autochthonous WNV lineage 2 in Spain confirmed in 2024. • Phylogenetic analysis links the strain to Central European WNV lineage 2. • Detection in an imperial eagle suggests previous local viral circulation. • Findings highlight the need for enhanced One Health surveillance in Spain.